TDP-43 leads to a decrease in carnitine and an increase in pyruvate and fatty acids [111,112], and SOD1 leads to a drop in arginine, lysine, ornithine, serine, threonine, and pyroglutamic acid [113] in ALS patients with these mutations. Here, SOD1 is linked to amyotrophic lateral sclerosis.